Vitamin K antagonists associated with arterial calcinosis

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1258, 2009-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

QOL effect of treatment duration with vitamin K antagonists

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 430, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Anticoagulant Prevention in Patients with Atrial Fibrillation: Alternatives to Vitamin K Antagonists

Current Pharmaceutical Design, Vol. 19, Iss. 21, 2013-06 ,pp. : 3816-3826

Bentham Science Publishers

Access to resources Recommend Favorite

Haemorrhagic Complications of Vitamin K Antagonists in the Elderly: Risk Factors and Management

By Pautas Eric

Drugs & Aging, Vol. 23, Iss. 1, 2006-01 ,pp. : 13-25

Adis International

Access to resources Recommend Favorite

Vitamin K antagonists linked to coronary calcification in AF patients

Reactions Weekly, Vol. 1, Iss. 1364, 2011-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Comparative Pharmacokinetics of Vitamin K Antagonists: Warfarin, Phenprocoumon and Acenocoumarol

By Ufer Mike

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1227-1246

Adis International

Access to resources Recommend Favorite